ArticleThe journal of pathology. Clinical research2024

AI-based intra-tumor heterogeneity score of Ki67 expression as a prognostic marker for early-stage ER+/HER2- breast cancer.

Wenqi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.